[1]
“Systemic Effects of GLP-1 and Dual GIP/GLP-1 Receptor Agonism in Obesity, Cardiovascular Health, and Neurodegeneration: Review Article”, JOPIR, vol. 3, no. 6, pp. 018–024, Dec. 2025, doi: 10.69613/akgbn956.